Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.46 EUR | +0.64% | +0.42% | -14.00% |
Apr. 19 | ITALY GROWTH WINNERS & LOSERS: Medica bullish; Plants in the red. | AN |
Apr. 18 | Intred appoints new board of directors; Daniele Peli chairman and Ad | AN |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With a 2024 P/E ratio at 22.58 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Sector: Integrated Telecommunications Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.00% | 160M | - | ||
+9.65% | 199B | B+ | ||
+5.25% | 167B | C | ||
+0.46% | 116B | A- | ||
-2.38% | 89.84B | B- | ||
+17.65% | 72.93B | B- | ||
+2.80% | 58.42B | B | ||
-5.07% | 50.97B | B | ||
-13.54% | 40.2B | B | ||
-34.49% | 36.67B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ITD Stock
- Ratings Intred S.p.A.